"First-time treatment success is important, above all, because
we want our canine patients to feel better fast. Research
shows CONVENIA delivers an assured course of treatment
with sustained concentrations above the MIC at the site of
the infection in as quickly as 2 hours," said Trettien.
6
In addition to treating infections quickly, there are other
benefi ts to fi rst-time treatment success. Successful
treatment with one dose, administered in the veterinary
clinic, means that there will be fewer missed doses and
potentially less need to re-treat with additional courses
of antibiotics.
Compliance is also an issue when it comes to antibiotic
stewardship. Choosing CONVENIA for your canine patients
who present with bacterial skin infections will give you
full confi dence that your patient received a full 14-day
course of antibiotics because you administered it. There's
no wondering if treatment failure is the result of less than
perfect owner compliance with missed doses during a
multi-week course of antibiotics, or if you are dealing with
a bacterial skin infection that is resistant to a particular
class of antibiotics.
CONVENIA provides an assured course of treatment and
guaranteed compliance; and as the studies show, a high
rate of fi rst-time treatment success for your patients. This
leads to peace of mind for your clients and control of the
antibiotic therapy for you.
Visit www.convenia.com/TVP to learn more about
CONVENIA for your canine patients with bacterial
skin infections. To learn more about the commitment
Zoetis has made to antibiotic stewardship, visit
responsibleantibiotics.com/TVP.
Photo credit: David Bird, DVM Daisy Lewis—Day 0 Daisy Lewis—Day 15
1
Zoetis Data on fi le. U.S. AIF DIARY Study.
2
Wright AK, Fadok V, Amodie D. First treatment success with injectable cefovecin sodium in dogs for superfi cial pyoderma, wounds, and
abscesses in different dog populations. Presented at: ISPPR 21st Annual International Meeting; May 21–25, 2016; Washington, DC.
3
Six R, Cherni J, Chesebrough R, et al. Effi cacy and safety of cefovecin in treating bacterial folliculitis, abscesses, or infected wounds in
dogs. J Am Vet Med Assoc. 2008;233(3):433-439.
4
Case included an initial skin cleansing with a diluted topical antiseptic.
5
Data on fi le. Convenia You Call the Shots Pet Owner Program, 2014; Zoetis Inc.
6
Stegemann MR, Sherington J, Blanchfl ower S. Pharmacokinetics and pharmacodynamics of cefovecin in dogs. J Vet Pharmacol Ther.
2006;29(6):501-511.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
©2016 Zoetis Services LLC. All rights reserved. AIF-00385B
IMPORTANT SAFETY INFORMATION:
People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to
CONVENIA. Do not use in dogs or cats with a history of allergic reactions to penicillins or
cephalosporins. Side effects for both dogs and cats include vomiting, diarrhea, decreased
appetite/anorexia and lethargy. See Brief Summary of Prescribing Information on page XX.
15.